Parenteral Amoxicillin Dosing in Adults
Standard intravenous amoxicillin dosing for adults is 1000 mg every 6 hours (4 g/day total), but current dose reductions recommended for renal impairment may lead to subtherapeutic concentrations and should be avoided for less susceptible pathogens. 1
Standard Dosing Regimen
- The typical IV dose is 1000 mg administered every 6 hours for hospitalized adults with normal renal function, providing adequate coverage for most susceptible organisms 1
- The first dose should be administered in a supervised clinical setting with resuscitation equipment readily available 2
- Infusion should occur over 15-20 minutes to minimize adverse reactions 2
Renal Impairment Adjustments: Critical Reconsideration
Traditional dose reduction strategies may be inadequate:
- Recent pharmacometric modeling demonstrates that recommended dose reductions result in clinically relevant reduction in probability of target attainment, particularly for pathogens with MIC ≥8 mg/L 1
- For patients with CKD-EPI of 10-30 mL/min/1.73 m², standard dose reductions achieve only 38-92% probability of target attainment versus 100% with standard dosing 1
- Amoxicillin clearance correlates strongly with body weight and CKD-EPI, allowing more precise individualized dosing 1
Traditional Dosing Adjustments (Use with Caution)
- Creatinine clearance >30 mL/min: No adjustment needed; use standard 1000 mg every 6 hours 3, 4
- Creatinine clearance 10-30 mL/min: Historically recommended 500-1000 mg every 8-12 hours, but this may be insufficient for MIC >2 mg/L 3, 4
- Creatinine clearance <10 mL/min (anephric): Expected half-life extends to 16 hours; traditional recommendation is 500 mg every 24 hours 3
Hemodialysis Patients
- Amoxicillin half-life during hemodialysis is 2.3-3.6 hours (versus 16 hours in anephric patients off dialysis) 3, 4
- Administer supplemental dose after each dialysis session to replace drug removed during the procedure 3, 4
- Loading dose should be based on patient weight, with maintenance doses adjusted for residual renal function 3
Critical Dosing Principles
The key principle is maintaining adequate peak concentrations while extending dosing intervals, rather than reducing individual doses 1
- For pathogens with MIC ≤2 mg/L, both reduced and standard doses achieve >90% probability of target attainment in renal impairment 1
- For less susceptible organisms (MIC 4-8 mg/L), standard dosing should be maintained despite renal impairment to ensure therapeutic concentrations 1
- The pharmacokinetic target is maintaining concentrations above MIC for 40% of the dosing interval 1
Safety Considerations
- High-dose amoxicillin (>300 mg/kg/day) carries risk of crystalluria and tubular obstruction, requiring adequate hydration and urine alkalinization 5
- Maximum daily dose should not exceed 6 g in adults without specific infectious disease consultation 5
- Monitor for hypersensitivity reactions, particularly during initial supervised administration 2
Common Pitfalls to Avoid
- Do not reduce individual dose size in renal impairment—this creates subtherapeutic peak concentrations; instead, extend the dosing interval 1, 3
- Do not rely solely on serum creatinine in elderly patients; calculate CKD-EPI or corrected creatinine clearance accounting for body weight 1, 3
- Do not forget supplemental dosing after hemodialysis, as significant drug removal occurs during dialysis 3, 4
- Verify pathogen MIC when available—traditional dose reductions may be adequate for highly susceptible organisms but insufficient for borderline susceptibility 1